Skip to main content
Top
Published in: Journal of Cardiovascular Magnetic Resonance 1/2020

Open Access 01-12-2020 | Research

Prevalence and pattern of cardiovascular magnetic resonance late gadolinium enhancement in highly trained endurance athletes

Authors: B. Domenech-Ximenos, M. Sanz-de la Garza, S. Prat-González, A. Sepúlveda-Martínez, F. Crispi, K. Duran-Fernandez, R. J. Perea, B. Bijnens, M. Sitges

Published in: Journal of Cardiovascular Magnetic Resonance | Issue 1/2020

Login to get access

Abstract

Background

Intensive endurance exercise may induce a broad spectrum of right ventricular (RV) adaptation/remodelling patterns. Late gadolinium enhancement (LGE) has also been described in cardiovascular magnetic resonance (CMR) of some endurance athletes and its clinical meaning remains controversial. Our aim was to characterize the features of contrast CMR and the observed patterns of the LGE distribution in a cohort of highly trained endurance athletes.

Methods

Ninety-three highly trained endurance athletes (> 12 h training/week at least during the last 5 years; 36 ± 6 years old; 53% male) and 72 age and gender-matched controls underwent a resting contrast CMR. In a subgroup of 28 athletes, T1 mapping was also performed.

Results

High endurance training load was associated with larger bi-ventricular and bi-atrial sizes and a slight reduction of biventricular ejection fraction, as compared to controls in both genders (p < 0.05). Focal LGE was significantly more prevalent in athletes than in healthy subjects (37.6% vs 2.8%; p < 0.001), with a typical pattern in the RV insertion points. In T1 mapping, those athletes who had focal LGE had higher extracellular volume (ECV) at the remote myocardium than those without (27 ± 2.2% vs 25.2 ± 2.1%; p < 0.05).

Conclusions

Highly trained endurance athletes showed a ten-fold increase in the prevalence of focal LGE as compared to control subjects, always confined to the hinge points. Additionally, those athletes with focal LGE demonstrated globally higher myocardial ECV values. This matrix remodelling and potential presence of myocardial fibrosis may be another feature of the athlete’s heart, of which the clinical and prognostic significance remains to be determined.
Literature
3.
go back to reference Van de Schoor FR, Aengevaeren VL, Hopman MTE, et al. Myocardial fibrosis in athletes. Mayo Clin Proc. 2016;91:1617–31.PubMedCrossRef Van de Schoor FR, Aengevaeren VL, Hopman MTE, et al. Myocardial fibrosis in athletes. Mayo Clin Proc. 2016;91:1617–31.PubMedCrossRef
5.
go back to reference Chan RH, Maron BJ, Olivotto I, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risck in patients with hypertrophic cardiomyopathy. Circulation. 2014;130:484–95.PubMedCrossRef Chan RH, Maron BJ, Olivotto I, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risck in patients with hypertrophic cardiomyopathy. Circulation. 2014;130:484–95.PubMedCrossRef
6.
go back to reference Bogaert J, Olivotto I. MR imaging in hypertrophic cardiomyopathy: from magnet to bedside. Radiology. 2014;273:329–48.PubMedCrossRef Bogaert J, Olivotto I. MR imaging in hypertrophic cardiomyopathy: from magnet to bedside. Radiology. 2014;273:329–48.PubMedCrossRef
7.
go back to reference Masci PG, Doulaptsis C, Bertella E, et al. Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure. Circ Heart Fail. 2014;7:448–56.PubMedCrossRef Masci PG, Doulaptsis C, Bertella E, et al. Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure. Circ Heart Fail. 2014;7:448–56.PubMedCrossRef
8.
go back to reference Trivax JE, Franklin BA, Goldstein JA, et al. Acute cardiac effects of marathon running. J ApplPhysiol. 2010;108:1148–53. Trivax JE, Franklin BA, Goldstein JA, et al. Acute cardiac effects of marathon running. J ApplPhysiol. 2010;108:1148–53.
9.
go back to reference Mousavi N, Czarnecki A, Kumar K, et al. Relation biomarkers and cardiac magnetic resonance imaging after marathon running. Am J Cardiol. 2009;103:1467–72.PubMedCrossRef Mousavi N, Czarnecki A, Kumar K, et al. Relation biomarkers and cardiac magnetic resonance imaging after marathon running. Am J Cardiol. 2009;103:1467–72.PubMedCrossRef
10.
go back to reference Gaudreault V, Tizon-Marcos H, Poirer P, et al. Transient myocardial tissue and function changes during a marathon in less fit marathon runners. Can J Cardiol. 2013;29(10):1269–76.PubMedCrossRef Gaudreault V, Tizon-Marcos H, Poirer P, et al. Transient myocardial tissue and function changes during a marathon in less fit marathon runners. Can J Cardiol. 2013;29(10):1269–76.PubMedCrossRef
11.
go back to reference Breuckmann F, Möhlenkamp S, Nassenstein K, et al. Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology. 2009;251(1):50–7.PubMedCrossRef Breuckmann F, Möhlenkamp S, Nassenstein K, et al. Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology. 2009;251(1):50–7.PubMedCrossRef
12.
go back to reference Bohm P, Schneider G, Linneweber L, et al. Right and left ventricular function and mass in male elite master athletes: a controlled contrast-enhanced cardiovascular magnetic resonance study. Circulation. 2016;133:1927–35.PubMedCrossRef Bohm P, Schneider G, Linneweber L, et al. Right and left ventricular function and mass in male elite master athletes: a controlled contrast-enhanced cardiovascular magnetic resonance study. Circulation. 2016;133:1927–35.PubMedCrossRef
14.
go back to reference Schelbert EB, Cao JJ, Sigurdsson S, et al. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA. 2012;308(9):890–6.PubMedPubMedCentralCrossRef Schelbert EB, Cao JJ, Sigurdsson S, et al. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA. 2012;308(9):890–6.PubMedPubMedCentralCrossRef
15.
go back to reference Barbier CE, Bjerner T, Johansson L, et al. Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group. J Am Coll Cardiol. 2006;48(4):765–71.PubMedCrossRef Barbier CE, Bjerner T, Johansson L, et al. Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group. J Am Coll Cardiol. 2006;48(4):765–71.PubMedCrossRef
16.
go back to reference La Gerche A, Baggish AL, Knuuti J, et al. Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death. JACC Cardiovasc Imaging. 2013;6:993–1007.PubMedCrossRef La Gerche A, Baggish AL, Knuuti J, et al. Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death. JACC Cardiovasc Imaging. 2013;6:993–1007.PubMedCrossRef
19.
go back to reference Kammerlander AA, Mazluf BA, ZotterTufaro C, et al. T1 mapping by CMR imaging: from histological validation to clinical implication. J Am Coll CardiolImg. 2016;9:14–23.CrossRef Kammerlander AA, Mazluf BA, ZotterTufaro C, et al. T1 mapping by CMR imaging: from histological validation to clinical implication. J Am Coll CardiolImg. 2016;9:14–23.CrossRef
20.
go back to reference Diao K-Y, Yang Z-G, Xu H-Y, et al. Hystologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis. J Cardiovasc MagnReson. 2016;18:92.CrossRef Diao K-Y, Yang Z-G, Xu H-Y, et al. Hystologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis. J Cardiovasc MagnReson. 2016;18:92.CrossRef
22.
go back to reference Schelbert EB, Piehler KM, Zareba KM, et al. Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage. J Am Heart Assoc. 2015;4:e002613.PubMedPubMedCentral Schelbert EB, Piehler KM, Zareba KM, et al. Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage. J Am Heart Assoc. 2015;4:e002613.PubMedPubMedCentral
23.
go back to reference Wilson M, O’Hanlon R, Prasad S, et al. Diverse patterns of myocardial fibrosis in lifelong veteran endurance athletes. J Appl Physiol. 2011;110(6):1622–6.PubMedPubMedCentralCrossRef Wilson M, O’Hanlon R, Prasad S, et al. Diverse patterns of myocardial fibrosis in lifelong veteran endurance athletes. J Appl Physiol. 2011;110(6):1622–6.PubMedPubMedCentralCrossRef
25.
go back to reference Mc Diarmid AK, Swoboda PP, Erhayiem B, et al. Ahtletic cardiac adapation in males is a consequence of elevated myocyte mass. Circ Cardiovasc Imaging. 2016;9:e003579. Mc Diarmid AK, Swoboda PP, Erhayiem B, et al. Ahtletic cardiac adapation in males is a consequence of elevated myocyte mass. Circ Cardiovasc Imaging. 2016;9:e003579.
26.
27.
go back to reference Schulz-Menger J, Bluemke DA, Bremerich J, et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc MagnReson. 2013;15:35.CrossRef Schulz-Menger J, Bluemke DA, Bremerich J, et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc MagnReson. 2013;15:35.CrossRef
28.
go back to reference Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138–44.PubMedCrossRef Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138–44.PubMedCrossRef
35.
go back to reference Merghani A, Maestrini V, Rosmini S, et al. Prevalence of subclinical coronary artery disease in masters endurance athletes with a low atherosclerotic risk profile. Circulation. 2017;136:126–37.PubMedCrossRef Merghani A, Maestrini V, Rosmini S, et al. Prevalence of subclinical coronary artery disease in masters endurance athletes with a low atherosclerotic risk profile. Circulation. 2017;136:126–37.PubMedCrossRef
37.
go back to reference Blyth KG, Groenning BA, Martin TN, et al. Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J. 2005;26(19):1993–9.PubMedCrossRef Blyth KG, Groenning BA, Martin TN, et al. Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J. 2005;26(19):1993–9.PubMedCrossRef
38.
go back to reference McCann GP, Beek AM, Vonk-Noordegraaf A, et al. Delayed contrast-enhanced magnetic resonance imaging in pulmonary arterial hypertension. Circulation. 2005;112(16):e268.PubMedCrossRef McCann GP, Beek AM, Vonk-Noordegraaf A, et al. Delayed contrast-enhanced magnetic resonance imaging in pulmonary arterial hypertension. Circulation. 2005;112(16):e268.PubMedCrossRef
40.
go back to reference Coelho-Filho OR, Mongeon FP, Mitchell R, et al. The role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease. Circ Cardiovasc Imaging. 2013;6(1):134–41.PubMedCrossRef Coelho-Filho OR, Mongeon FP, Mitchell R, et al. The role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease. Circ Cardiovasc Imaging. 2013;6(1):134–41.PubMedCrossRef
Metadata
Title
Prevalence and pattern of cardiovascular magnetic resonance late gadolinium enhancement in highly trained endurance athletes
Authors
B. Domenech-Ximenos
M. Sanz-de la Garza
S. Prat-González
A. Sepúlveda-Martínez
F. Crispi
K. Duran-Fernandez
R. J. Perea
B. Bijnens
M. Sitges
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Journal of Cardiovascular Magnetic Resonance / Issue 1/2020
Electronic ISSN: 1532-429X
DOI
https://doi.org/10.1186/s12968-020-00660-w

Other articles of this Issue 1/2020

Journal of Cardiovascular Magnetic Resonance 1/2020 Go to the issue